Accessibility Menu
Praxsyn logo

Praxsyn

(OTC) PXYN

Current Price$0.00
Market Cap$600.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2010)-100%
5 Year-99%
1 Year+0%
1 Month+0%

Praxsyn Financials at a Glance

Market Cap

$600.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$20.47M

Net Income (TTM)

$2.68M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

8.35 (High)

Price

$0.00

Volume

126,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

PXYN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Praxsyn

Industry

Pharmaceuticals

Headquarters

Las Vegas, NV, US

PXYN Financials

Key Financial Metrics (TTM)

Gross Margin

29.39%

Operating Margin

-240.85%

Net Income Margin

-695.52%

Return on Equity

-20.21%

Return on Capital

-4.71%

Return on Assets

-5.08%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$600.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

634.67M

Volume

126.00K

Avg. Volume

2.22K

Financials (TTM)

Gross Profit

$17.53M

Operating Income

$5.15M

EBITDA

$5.17M

Operating Cash Flow

-$10.81M

Capital Expenditure

-$288.16K

Free Cash Flow

-$11.10M

Cash & ST Invst.

$289.64K

Total Debt

$2.10M

Praxsyn Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2019YOY CHG

Revenue

$41.93K

-99.8%

Gross Profit

$24.46K

-99.8%

Gross Margin

58.33%

N/A

Market Cap

$600.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$9.09

N/A

Employees

66

N/A

Net Income

-$142.00K

-104.5%

EBITDA

-$117.00K

-102.1%

Quarterly Fundamentals

Name
Q3 2019YOY CHG

Total Cash

$289.64K

-94.0%

Total Debt

$2.10M

-41.7%

Accounts Receivable

$11.06M

+54.5%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$2.10M

-38.4%

Return on Assets

-5.08%

N/A

Return on Invested Capital

-7.78%

N/A

Free Cash Flow

-$5.90M

+14.6%

Operating Cash Flow

-$5.77M

+16.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IPAHInterpharm Holdings, Inc.
$0.00+0.00%
RBIIRising Biosciences, Inc.
$0.00+0.00%
MHTXManhattan Scientifics, Inc.
$0.00+0.00%
DNAGDNAPrint Genomics, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PATHUiPath
$11.68-0.01%
FRMIFermi
$6.59-0.10%
INTCIntel
$109.84-0.02%
ONDSOndas
$7.26-0.05%

Questions About PXYN

What is the current price of Praxsyn?

Praxsyn is trading at $0.00 per share.

What is the 52-week range for Praxsyn?

Over the past 52 weeks, Praxsyn has traded between $0.00 and $0.00.

How much debt does Praxsyn have?

Praxsyn total debt is unavailable.

How much cash does Praxsyn have on hand?

Praxsyn does not have cash on hand data available.

What is Praxsyn’s dividend yield?

Praxsyn does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.